THYMOMA TYPE B3

Clinical trials for THYMOMA TYPE B3 explained in plain language.

Never miss a new study

Get alerted when new THYMOMA TYPE B3 trials appear

Sign up with your email to follow new studies for THYMOMA TYPE B3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for rare cancer: drug duo tested after chemo fails

Disease control Completed

This study tested whether combining two existing cancer drugs, pembrolizumab and lenvatinib, could help control advanced thymic cancer that had worsened after standard chemotherapy. It enrolled 43 adults whose cancer could not be cured by surgery or radiation. The main goal was t…

Matched conditions: THYMOMA TYPE B3

Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

THYMOMA TYPE B3

Get alerted when new THYMOMA TYPE B3 trials appear

New hope for rare cancer: drug duo tested after chemo fails